Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

Novartis, Amgen Divvy Global Marketing of New Migraine Drug

Novartis, Amgen Divvy Global Marketing of New Migraine Drug

Fresenius and Merck Stocks Top DAX on Biosimilars Deal

Fresenius and Merck Stocks Top DAX on Biosimilars Deal

Becton Dickinson Announces $24 Billion Acquisition of C.R. Bard

Becton Dickinson Announces $24 Billion Acquisition of C.R. Bard

Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector

Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector

Biotech Movers: XBiotech, Atara, Bellicum

Biotech Movers: XBiotech, Atara, Bellicum

What to Expect From European Pharmaceuticals' First Quarter Results

What to Expect From European Pharmaceuticals' First Quarter Results

Biotech Movers: Organovo, Endo, Omeros

Biotech Movers: Organovo, Endo, Omeros

Merger Challenges, FDA Concerns Dampen Abbott Gains Despite Strong First Quarter

Merger Challenges, FDA Concerns Dampen Abbott Gains Despite Strong First Quarter

Biotech Movers: Ultragenyx Jumps on Phase Three Burosumab Data

Biotech Movers: Ultragenyx Jumps on Phase Three Burosumab Data